Drug Type Small molecule drug |
Synonyms repurposed imipramine(Ennaid Therapeutics) |
Target |
Mechanism fascin modulators(fascin actin-bundling protein 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | AU | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | CA | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | US | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | EU | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | JP | 26 Mar 2021 | |
Colorectal Cancer | Preclinical | EU | 26 Mar 2021 |